Navigation Links
AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
Date:9/5/2007

http://www.akelapharma.com Toronto Stock Exchange Symbol: AKL

MONTREAL, Sept. 5 /PRNewswire-FirstCall/ - AKELA Pharma Inc., (TSX: AKL), a drug development company focused on developing therapies for the inhalation, pain and CNS markets, today announced positive results from the double-blind extension part of its Fentanyl TAIFUN(R) Phase IIb trial. The results demonstrated statistically significant differences compared to placebo in the measured primary and secondary efficacy variables resulting in faster and superior pain relief. Fentanyl TAIFUN(R) is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform.

A total of 50 patients were randomized and started the extension part of the study. In the Intent-To-Treat (ITT) population, the median time to significant pain relief in the Fentanyl TAIFUN(R) group as measured by a decrease of at least 2 points on the numerical pain scale (NPS) was 5.2 minutes, which was statistically significantly faster when compared to placebo (P=0.007). The mean difference in sum of pain intensity difference (SPID) was also statistically significantly in favor of Fentanyl TAIFUN(R) for the whole 60 min pain episode (P=0.050). This was already seen in numerical pain scale scores up to 15 minutes (P=0.008) when compared to placebo.

"We are extremely satisfied to have demonstrated beyond doubt the faster and superior pain relief provided by Fentanyl TAIFUN(R) to patients. The additional knowledge and data accumulated during this clinical trial, as well as the positive feed-back by the authorities during the recent End-of-Phase II meetings makes us confident when preparing our Phase III study protocols." said Dr. Halvor Jaeger, Chief Executive Officer of Akela Pharma Inc.

Phase IIb for Fentanyl TAIFUN(R) was a multi-center, multinational clinical trial in cancer patients with severe persistent pain on main
'/>"/>

SOURCE AKELA PHARMA INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. India to benefit from pharma companies move
2. South Africa Wins landmark case against pharmaceutical giants
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Pharma cos must forge Strategic alliances
6. Setting up a new pharmaceutical industry in India
7. Medicis Pharmaceutical company enters pediatric market
8. Supply of Radiopharmaceuticals Hampered by Attacks
9. Pharma majors gear to supply anti-anthrax drug
10. Pharmacies in for a dose of bitter medicine
11. Andhra Pradesh to set up Pharma City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Cubit Labs is pleased to announce ... Play Store. , The popular cross platform contact sharing ... this year, gleaning a solid 5 star rating in ... has never been so easy and I highly recommend ... steps." - CrackBerry.com, View full App review here: ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 Rinovum ... home-use conception assistance device on the market cleared by ... in stores and online at http://www.storkotc.com . , ... dream of having a baby is delayed by infertility1 ... first step to optimize their chances to conceive. ...
(Date:9/23/2014)... by researchers from the University of Cambridge has found that ... childhood leaves a ,signature, in the brain. The results ... Cortex . , The researchers studied 80 adult men ... who did not. They found that language delay was associated ... regions, including the temporal lobe, insula, ventral basal ganglia, which ...
(Date:9/23/2014)... 2014 Névo takes a bold step ... and adding advanced activity tracking and phone notifications for ... distance, calories burned, and more. , http://www.nevowatch.com ... healthy habits in their busy lives to look and ... that produce healthy results, but until now, style played ...
(Date:9/23/2014)... Medicine in Motion (MIM) is proud to ... 711 W. 38th, Suite G4. After serving the area’s sports ... increased demand for MIM’s superior care led to the need ... extremely excited about bringing our high-quality brand of sports medicine ... in Motion. “We’ll continue to provide patients with the same ...
Breaking Medicine News(10 mins):Health News:YOUnify for Android is Now Available in the Google Play Store 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4Health News:Presence or absence of early language delay alters anatomy of the brain in autism 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Austin Sports Medicine Practice to Host Grand Opening Event for Second Location 2
... Creates New Opportunities for Expansion of HIFU Technology, ... (USHIFU), the,distributor and provider of non-invasive high intensity ... has completed the acquisition,of Focus Surgery, Inc. (FSI) ... Sonablate(R) 500, an image-guided acoustic ablation,device. This acquisition ...
... of today,s,announcement that Attorney General Mike Cox is filing ... Coalition for a Fair and,Competitive Insurance Market is calling ... Cross Blue Shield of Michigan (BCBSM) to use their,unfair ... insurance., "We were confident when we raised this ...
... 2 A Miami resident was,sentenced to 130 months ... the,Medicare program, Acting Assistant Attorney General Matthew Friedrich of,the ... the Southern,District of Florida announced today., Gustavo Smith, ... for,the Southern District of Florida by Judge Marcia G. ...
... could one day help tailor treatments to individual patients, study ... technique for finding and analyzing stray cancer cells in the ... doctors to one day not only determine the genetic "signature" ... and adjust treatments accordingly. , "I think this is ...
... QC, July 2 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... a complete response to,the Food and Drug Administration ... the FDA,s Deputy Director, Center for Drug Evaluation,and ... regulatory path towards,potential U.S. approval of the Company,s ...
... July 2, 2008 -- Compact, bedside brain-activity monitors ... Washington University School of Medicine in St. Louis ... clinicians in monitoring for electrical seizures until confirmation ... an article published in the June issue of ...
Cached Medicine News:Health News:USHIFU, LLC Completes Acquisition of Focus Surgery, Inc. 2Health News:Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 3Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 2Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 3Health News:Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 3
(Date:9/22/2014)... BURLINGTON, Mass. , Sept. 22, 2014 Decision ... Chilean pharmaceutical market is expected to be worth $2 billion ... 11.3 percent over the next five years (to 2018). This ... growth of 4.8 percent in 2013 and 4.9 percent expected ... pharmaceutical landscape is small but highly competitive. The ...
(Date:9/22/2014)... 22, 2014 Research and Markets ... "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... to their offering. On the ... technologies market has been divided into eight major ... hydrothermal, and hydromechanical ablation technologies. The light/laser ablation ...
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
Breaking Medicine Technology:Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... The 2201 is ideal for applications ... application of heat. , ,The autoclavable ... assortment of reusable thermal cautery electrodes, ... flexibility to perform a wide variety ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: